Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$432M |
| 3 |
Abbott
ABT
|
+$420M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$277M |
Top Sells
| 1 |
Sherwin-Williams
SHW
|
+$472M |
| 2 |
Bank of America
BAC
|
+$426M |
| 3 |
TE Connectivity
TEL
|
+$399M |
| 4 |
Atlassian
TEAM
|
+$364M |
| 5 |
Goldman Sachs
GS
|
+$348M |
Sector Composition
| 1 | Technology | 32.59% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.8% |
| 4 | Financials | 9.76% |
| 5 | Industrials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Penumbra
PEN
$11.1B
| $64.7M | 0.04% |
257,325
-13,158
| -5% | -$3.31M |
|
327
MSC Industrial Direct
MSM
$5.17B
| $64.6M | 0.04% |
637,807
-267,190
| -30% | -$27.1M |
|
328
Roper Technologies
ROP
$55.9B
| $64.3M | 0.04% |
117,919
-8,226
| -7% | -$4.49M |
|
329
Cardinal Health
CAH
$36B
| $63.5M | 0.04% |
630,184
-88,764
| -12% | -$8.95M |
|
330
Wendy's
WEN
$1.89B
| $63.4M | 0.04% |
3,252,919
+18,543
| +0.6% | +$361K |
|
331
Frontdoor
FTDR
$4.75B
| $63.1M | 0.04% |
1,791,785
-884,126
| -33% | -$31.1M |
|
332
Revolution Medicines
RVMD
$7.68B
| $63.1M | 0.04% |
2,199,480
-41,259
| -2% | -$1.18M |
|
333
Structure Therapeutics
GPCR
$1.2B
| $62.8M | 0.04% |
1,544,416
-546,907
| -26% | -$22.3M |
|
334
4D Molecular Therapeutics
FDMT
$326M
| $62.7M | 0.04% |
3,093,296
+346,961
| +13% | +$7.03M |
|
|
CRGX
335
DELISTED
CARGO Therapeutics
CRGX
| $62.6M | 0.04% |
+2,702,731
| New | +$62.6M |
|
336
Bruker
BRKR
$4.73B
| $61.7M | 0.04% |
839,639
-1,863
| -0.2% | -$137K |
|
337
Mirum Pharmaceuticals
MIRM
$3.89B
| $60.9M | 0.04% |
2,062,551
+138,791
| +7% | +$4.1M |
|
338
Descartes Systems
DSGX
$9.19B
| $60.3M | 0.04% |
714,203
+2,327
| +0.3% | +$196K |
|
339
IPG Photonics
IPGP
$3.5B
| $59.8M | 0.04% |
550,622
-149,208
| -21% | -$16.2M |
|
|
CSW
340
CSW Industrials, Inc.
CSW
$4.48B
| $59.5M | 0.04% |
287,074
-15,397
| -5% | -$3.19M |
|
341
Nordson
NDSN
$12.7B
| $58.5M | 0.03% |
221,539
-113,761
| -34% | -$30.1M |
|
342
PepsiCo
PEP
$196B
| $58.1M | 0.03% |
341,824
-16,921
| -5% | -$2.87M |
|
343
Entegris
ENTG
$12.3B
| $57.9M | 0.03% |
483,297
-81,587
| -14% | -$9.78M |
|
344
GE HealthCare
GEHC
$35.7B
| $57.6M | 0.03% |
744,878
-148,445
| -17% | -$11.5M |
|
345
Commercial Metals
CMC
$6.54B
| $56.7M | 0.03% |
1,133,953
+4,050
| +0.4% | +$203K |
|
346
Alcon
ALC
$39B
| $56.4M | 0.03% |
722,935
-79,605
| -10% | -$6.21M |
|
347
Entergy
ETR
$38.8B
| $56.3M | 0.03% |
1,112,540
+22,848
| +2% | +$1.16M |
|
348
Black Hills Corp
BKH
$4.26B
| $55.8M | 0.03% |
1,034,591
-64,762
| -6% | -$3.49M |
|
349
NRG Energy
NRG
$29.5B
| $55.7M | 0.03% |
1,076,686
-5,653
| -0.5% | -$292K |
|
350
Pure Storage
PSTG
$25.9B
| $55.5M | 0.03% |
1,557,443
+572,038
| +58% | +$20.4M |
|